Diagnostic Medical Systems

Equities

ALDMS

FR0012202497

Advanced Medical Equipment & Technology

Market Closed - Euronext Paris 08:01:58 2024-04-26 am EDT 5-day change 1st Jan Change
1.04 EUR 0.00% Intraday chart for Diagnostic Medical Systems +4.63% -8.37%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Diagnostic Medical Systems S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Rhythm Biosciences Seeks to Raise AU$6.6 Million Via Rights Offer; Shares Fall 29% MT
Lantheus Sued by Novartis Entities for Patent Infringement DJ
2cureX Signs Contract with Notified Body in EU for Certification of Cancer Tests MT
Diagnostic Medical Systems S.A. completed the acquisition of Solutions For Tomorrow AB from Verso Capital Oy and Other Shareholder. CI
Diagnostic Medical Systems S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Diagnostic Medical Systems S.A. signed an agreement to acquire Solutions For Tomorrow AB from Verso Capital Oy for SEK 44.8 million. CI
Shineco Unit's Cardiac Test Receives Regulatory Approval in China MT
Global markets live: Stellantis, Diageo, Boeing, Shell, Barclays... Our Logo
DMS : Euroland initiates buy coverage CF
Eurobio Scientific Secures IVDR CE Marking for Diagnostic Tests MT
Diagnostic Medical Systems S.A. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Diagnostic Medical Systems S.A. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Sector Update: Health Care Stocks' Recovery Stall Short of Positive Ground MT
Sector Update: Health Care Stocks Sinking as Investor Attention Looks to Other Sectors MT
Sector Update: Health Care MT
Diagnostic Medical Systems Unit Receives Order for Radiology Tables in Italy MT
PCL to Raise 3 Billion Won via Share Issuance; Shares Jump 4% MT
An unknown buyer signed a memorandum of understanding to acquire 43.41% stakes of Hybrigenics SA from Diagnostic Medical Systems S.A.. CI
Diagnostic Medical Systems S.A. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
MedMira Provides Update on New In Vitro Diagnostic Medical Devices Regulation (IVDR) in the European Market MT
Diagnostic Medical Systems S.A. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Lantheus Holdings Posts Higher Q4 Adjusted Earnings, Revenue; Shares Rise Pre-Bell MT
Diagnostic Medical Systems Takes Majority Stake In Asit Biotech MT
CES Management SA agreed to acquire DMS Wellness division of Diagnostic Medical Systems from Diagnostic Medical Systems S.A.. CI
Chart Diagnostic Medical Systems
More charts
Diagnostic Medical Systems (DMS) is France's leader in the development, design, and production of imaging systems for digital and conventional radiology and osteodensitometry. The group's activity is organized around two sectors: - radiology equipment and osteodensitometers sales: mobile radiology units, floating table tops, operating room mobile amplifiers, ultrasound osteodensitometers (designed to chart the bone micro-architecture) and X ray osteodensitometers (designed to measure bone density), etc. The group also proposes devices distribution and maintenance activities; - development of biotechnology solutions: in the fields of arthrosis treatment and regenerative medicine. Products and services are marketed primarily by exclusive retailers. Net sales (not including sold divisions) are distributed geographically as follows: Europe (62.6%), North and South America (17.7%), Asia (6.8%), Middle East (4.5%), Africa (3.8%), Oceania (1.1%) and other (3.5%).
More about the company
  1. Stock Market
  2. Equities
  3. ALDMS Stock
  4. News Diagnostic Medical Systems
  5. 2cureX Signs Contract with Notified Body in EU for Certification of Cancer Tests